ETF Series Solutions Trust Range Cancer Therapeutics ETF

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNCR and other ETFs, options, and stocks.

About CNCR

CNCR tracks an equal-weighted index of companies currently developing oncology drugs or selling cancer therapeutic products. 

Index-Tracked
Range Oncology Therapeutics TR USD
Index-TrackedRange Oncology Therapeutics TR USD
Category
Health
CategoryHealth
Number of holdings
68
Number of holdings68
Inception Date
Oct 13, 2015
Inception DateOct 13, 2015

What's in this fund

Sectors

As of April 29, 2025
Healthcare100.00%

Top 10 Holdings (18.20% of total assets)

As of April 29, 2025
NameSymbol% Assets
Fate TherapeuticsFATE2.15%
Summit TherapeuticsSMMT1.95%
Sutro BiopharmaSTRO1.83%
ArvinasARVN1.80%
Innate PharmaIPHA1.77%
Syndax PharmaceuticalsSNDX1.77%
SchrodingerSDGR1.75%
Nuvation BioNUVB1.75%
ExelixisEXEL1.72%
Janux TherapeuticsJANX1.71%

CNCR Key Statistics

AUM
7.83M
AUM7.83M
Price-Earnings ratio
-2.68
Price-Earnings ratio-2.68
30-Day yield
-0.68
30-Day yield-0.68
Average volume
2.47K
Average volume2.47K
High today
—
High today—
Low today
—
Low today—
Open price
$10.05
Open price$10.05
Volume
0.00
Volume0.00
52 Week high
$16.27
52 Week high$16.27
52 Week low
$7.88
52 Week low$7.88
Expense ratio
0.79
Expense ratio0.79
View Prospectus and Reports

Average Annual Return

All investments involve risks, including the loss of principal. Performance data represents past performance and is no guarantee of future results. Investment returns and principal value will fluctuate and are subject to market volatility. An investment, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance data quoted.